Skip to main content
Mitsui Chemicals, Inc. logo

Mitsui Chemicals, Inc. — Investor Relations & Filings

Ticker · 4183 ISIN · JP3888300005 LEI · 353800H2UB5ZEZRZQC02 T Manufacturing
Open in API
Filings indexed 110 across all filing types
Latest filing 2025-04-08 Major Shareholding Noti…
Country JP Japan
Listing T 4183

About Mitsui Chemicals, Inc.

https://jp.mitsuichemicals.com/en/index…

Mitsui Chemicals, Inc. is a global chemical company that develops, manufactures, and sells a diverse range of chemical products. The company's operations are structured around key business domains: Life & Healthcare Solutions, Mobility Solutions, ICT Solutions, and Basic & Green Materials. Its product portfolio spans from foundational petrochemicals, such as olefins and phenols, to high-performance and functional materials, including specialty polymers, films, sheets, and nonwovens. These materials are integral to numerous industries, including automotive, electronics, packaging, and medical care. The company is focused on providing innovative materials and solutions to address evolving social needs and contribute to a sustainable future.

Recent filings

Filing Released Lang Actions
変更報告書
Major Shareholding Notification Classification · 100% confidence The document is titled "株券等の大量保有の状況の開示に関する内閣府令 第一号様式 大量保有報告書" (Cabinet Office Ordinance on Disclosure of Large Volume Shareholdings Form No. 1 Large Volume Holding Report). This is a specific Japanese regulatory filing form used to report when an entity acquires or disposes of more than 5% of a company's outstanding shares. The content details the filer (三井化学株式会社 - Mitsui Chemicals, Inc.), the issuer (株式会社ＤＮＡチップ研究所 - DNA Chip Research Institute), the change in shareholding percentage (from 13.85% to 68.08%), and the acquisition details. This directly corresponds to a notification of a major shareholding change, which is classified as 'Major Shareholding Notification' (MRQ) in the provided definitions, as it reports changes in significant share ownership levels crossing thresholds.
2025-04-08 Japanese
公開買付報告書
M&A Activity Classification · 100% confidence The document is titled "公開買付報告書" (Tender Offer Report) and is submitted to the "関東財務局長" (Kanto Local Finance Bureau Director). It details the results of a tender offer (公開買付け) for the shares of 株式会社ＤＮＡチップ研究所 by 三井化学株式会社. The content explicitly covers the tender offer period, the success/failure of the offer, the number of shares acquired, and the resulting shareholding percentage. This directly corresponds to the regulatory filing concerning a takeover bid or merger activity, which is classified as M&A Activity (TAR) in the provided definitions, although the specific Japanese term for a tender offer report is often associated with takeover/merger processes. Given the options, 'TAR' (M&A Activity) is the most appropriate fit for a formal Tender Offer Report detailing the outcome of an acquisition attempt, as opposed to a general regulatory filing (RNS) or a general capital change (SHA).
2025-04-08 Japanese
訂正発行登録書
Capital/Financing Update Classification · 98% confidence The document is titled "訂正発行登録書" (Corrected Shelf Registration Statement) and is filed with the Kanto Local Finance Bureau ("関東財務局長"). It explicitly mentions the type of security being registered as "社債" (Corporate Bonds) and refers to the original Shelf Registration Statement filed on October 16, 2023. This document is a formal regulatory filing related to the issuance of securities (debt financing) and is a correction to a prior filing. While it relates to financing (CAP), the specific nature of correcting a formal registration statement for debt issuance, which is a mandatory disclosure document, places it firmly in the category of general regulatory filings that are not covered by the more specific codes like ER, IR, or 10-K. Given the options, 'Regulatory Filings' (RNS) is the most appropriate general category for a corrected shelf registration statement that doesn't fit the specific financing/capital change codes (CAP/SHA) which usually relate to announcements of intent or completion, rather than the formal registration document itself. However, since the document is fundamentally about a capital/financing activity (issuance of corporate bonds), and 'CAP' is defined as 'Updates on company fundraising, financing activities, or capital structure changes,' this corrected registration statement is a core part of that financing activity. Given the highly specific nature of the filing (a corrected shelf registration for bonds), and the lack of a specific code for 'Shelf Registration Statement Correction,' I must choose between CAP (Financing Update) and RNS (General Regulatory Filing). Since it is a formal, required filing related to debt issuance, it is a regulatory document. If 'CAP' is interpreted broadly to include the formal documentation of financing activities, it fits. If we strictly follow the definitions, a formal registration document correction is best categorized as a general regulatory filing (RNS) unless it is an earnings release or annual report. Given the context of financial reporting databases, formal registration documents often fall under RNS if a more specific code isn't available. However, 'CAP' covers 'financing activities.' I will lean towards RNS as it is a correction to a formal registration document, which is a type of regulatory disclosure not covered by the other specific codes.
2025-03-31 Japanese
臨時報告書
Share Issue/Capital Change Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and is submitted to the Kanto Local Finance Bureau Director on March 31, 2025. The content explicitly details a resolution made by the Board of Directors regarding the disposal of treasury stock to an Employee Stock Ownership Plan (ESOP) under a restricted stock incentive plan. This type of filing in Japan, reporting a significant corporate action like a stock issuance/disposal outside of regular periodic reports, corresponds to a timely disclosure or extraordinary report. Given the options, this is a specific corporate action disclosure. Since it involves the issuance/disposal of shares (though via treasury stock), it relates to capital structure changes. However, the primary nature is a mandatory, timely disclosure of a specific corporate event (stock compensation/grant) required under Japanese regulations (FIEA Article 24-5, Paragraph 4). In the context of the provided US-centric codes, a mandatory, non-periodic, specific corporate action disclosure often falls under a general regulatory filing category if a more specific one doesn't fit perfectly. The document details a 'Share Issue/Capital Change' (SHA) as it involves the disposal of shares, but the format is that of a mandatory timely disclosure ('臨時報告書'). Since the document is a full, detailed report of the transaction (not just an announcement of a report), and it concerns the issuance/disposal of shares, SHA is a strong candidate. However, the Japanese term '臨時報告書' (Rinji Hokokusho) is a broad category for timely disclosures. Given the detailed nature of the transaction (stock compensation plan details, transfer restrictions, etc.), and the fact that it is a full report rather than just an announcement of a report, SHA (Share Issue/Capital Change) is the most specific fit among the choices for the *content* (disposal of treasury stock for compensation). If the document were purely an announcement stating 'We published the details,' RPA or RNS would apply. Since this *is* the detailed filing, SHA is appropriate.
2025-03-31 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document title is "自己株券買付状況報告書（法24条の６第１項に基づくもの）" which translates to 'Report on the Status of Treasury Stock Acquisition (Based on Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act)'. This document details the company's treasury stock acquisition activities during a specific reporting period (February 1 to February 28, 2025). This specific regulatory filing in Japan concerns the company's own share transactions. Reviewing the provided definitions, the category 'Transaction in Own Shares (Code: POS)' is the most appropriate fit, as it covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. The document is a detailed report, not an announcement of a report, so RPA/RNS is not the primary classification.
2025-03-13 Japanese
訂正発行登録書
Capital/Financing Update Classification · 95% confidence The document is explicitly titled "訂正発行登録書" (Correction Registration Statement) and is filed with the Kanto Local Finance Bureau ("関東財務局長"). It pertains to "社債" (Corporate Bonds) and references a previous "発行登録書" (Registration Statement) from 2023. The filing reason states it is submitted based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act, referencing an accompanying Extraordinary Report (臨時報告書). This type of filing relates directly to the issuance or registration of securities (debt in this case) and capital structure changes, but the specific nature of correcting a registration statement for debt issuance points most closely to financing activities. Among the provided codes, 'CAP' (Capital/Financing Update) is the most appropriate fit for updates related to bond issuance registration, especially when a correction is being filed. It is not a general earnings release (ER), an annual report (10-K), or a simple dividend notice (DIV).
2025-02-28 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.